Increased levels of a 21-kDa protein in the circulation of tumor-bearing patients.

Channa Shalitin(Technion – Israel Institute of Technology), Livne Pm, Ron Epelbaum(University of Bern), Ruth Segal(Rambam Health Care Campus), M. Werner, Clari Valansi(Technion – Israel Institute of Technology), Boaz Moskovitz(Bnai Zion Medical Center)
PubMed
January 1, 1994
Cited by 9

Related Papers

Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
|Nutrition and Cancer|2010|279
Endocrinology: Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy
|Human Reproduction|1996|266